StonvexLoading…
StonvexStonvexStonvexCore line items from ADP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $5.51B | $16.47B | $10.53B | $5.18B | $20.56B |
Operating Income | Not available | $4.47B | $2.69B | $1.31B | $5.31B |
Net Income | Not available | $3.43B | $2.08B | $1.01B | $4.08B |
EPS (Diluted) | $2.62 | $8.49 | $5.12 | $2.49 | $9.98 |
Total Assets | Not available | $64.48B | $84.64B | $54.32B | $53.37B |
Total Liabilities | Not available | $58.13B | $78.25B | $47.95B | $47.18B |
Cash & Equivalents | Not available | $3.23B | $2.42B | $2.48B | $3.35B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 400.60M | 403.00M | 404.90M | 405.30M |